Immune impacts of infant whole-cell and acellular pertussis vaccination on co-administered vaccines

Whole-cell (wP) first brings strength
boosting broad immune defense
in mixed schedules, start with wP
whole-cell pertussis vaccine
acellular pertussis vaccine
pneumococcal conjugated vaccine
randomised controlled trial
Bayes
Australia

Gladymar Pérez Chacón*, Sonia McAlister*, James Totterdell, Marie J. Estcourt, Julie A. Marsh, Mark Jones, Kirsten P. Perrett, Dianne E. Campbell, Nicholas Wood, Michael Gold, Claire S. Waddington, Michael O’Sullivan, Nigel Curtis, Ushma Wadia, Peter B. McIntyre, Patrick G. Holt, Tom Snelling, Peter C. Richmond. Immune impacts of infant whole-cell and acellular pertussis vaccination on co-administered vaccines. Journal of Infection (2025). doi: 10.1016/j.jinf.2025.106515
*Indicates equal contribution.

Published

May 2025

Doi

Summary

Objectives

We compared the effect of a heterologous wP/aP/aP primary series (hereafter mixed wP/aP) versus a homologous aP/aP/aP primary schedule (hereafter aP-only) on antibody responses to co-administered vaccine antigens in infants and toddlers.

Methods

We randomised Australian infants in a 1:1 ratio to receive either a mixed wP/aP schedule (pentavalent diphtheria-tetanus-wP-hepatitis B-Haemophilus influenzae type b; DTwP-HepB-Hib vaccine at 6 weeks old, followed by hexavalent DTaP-inactivated poliovirus vaccine (IPV)-HepB-Hib vaccine at 4 and 6 months old) or aP-only priming doses of hexavalent DTaP-IPV-HepB-Hib vaccine at the same ages. All infants received 13-valent pneumococcal conjugate vaccine (13vPCV) at 6 weeks, 4 and 12 months of age and DTaP-IPV and Hib vaccine boosters at 18 months. We assessed whether the wP/aP schedule is non-inferior to the aP-only schedule for co-administered vaccine antigens (geometric mean ratio [GMR] >2/3). Registration: ACTRN12617000065392p.

Results

Between March 2018 and January 2020, 150 infants were randomised (75 per arm). Responses to all 13vPCV serotypes and Hib-PRP at 6, 7, 18, and 19 months old, as well as HBsAg at 6 and 7 months old, were non-inferior (>90% probability).

Conclusion

A mixed wP/aP schedule resulted in non-inferior IgG responses to co-administered vaccine antigens compared to the standard aP-only schedule for pertussis primary immunisation.

License

This article is available under CC BY-NC-ND 4.0 license and permits non-commercial use of the work as published, without adaptation or alteration provided the work is fully attributed.

Citation

@article{chacon2025immune,
  title={Immune impacts of infant whole-cell and acellular pertussis vaccination on co-administered vaccines},
  author={P{\'e}rez Chac{\'o}n, Gladymar and McAlister, Sonia and Totterdell, James and Estcourt, Marie J and Marsh, Julie A and Jones, Mark and Perrett, Kirsten P and Campbell, Dianne E and Wood, Nicholas and Gold, Michael and others},
  journal={Journal of Infection},
  pages={106515},
  year={2025},
  publisher={Elsevier}
}